Adam Craig, MD, PhD, is the President and CEO of CTI BioPharma, a biopharmaceutical company specializing in blood-related cancers.
Adam Craig, MD, PhD, is the President and CEO of CTI BioPharma, a biopharmaceutical company specializing in blood-related cancers. He was appointed to lead the company's strategic direction and clinical operations, bringing expertise in hematology and oncology clinical research.
Full founder directory · Investor directory · Company funding database · Fundraising library